Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma
- 31 December 2006
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 169 (6), 2171-2180
- https://doi.org/10.2353/ajpath.2006.051078
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphomaOncogene, 2005
- Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell LymphomaJournal of Clinical Oncology, 2005
- mTOR, translational control and human diseaseSeminars in Cell & Developmental Biology, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Upstream and downstream of mTORGenes & Development, 2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochromec ReleasePublished by Elsevier BV ,2003
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- PKB/AKT: functional insights from genetic modelsNature Reviews Molecular Cell Biology, 2001